During the past decade, Texas Institute for Neurological Disorders conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Institute for Neurological Disorders" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Amgen" with 1 trials sponsored, "BioVie Inc." with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Institute for Neurological Disorders" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Texas Institute for Neurological Disorders" are "Episodic Migraine" (1 trials), "Idiopathic Parkinson Disease" (1 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "Texas Institute for Neurological Disorders" in a lesser frequency.

Most popular intervention types in "Texas Institute for Neurological Disorders" are "Drug" (6 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fenebrutinib" (2 trials), "Ocrelizumab" (2 trials), "AMG334" (1 trials), "AboBoNT-A" (1 trials) and "Antihistamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texas Institute for Neurological Disorders" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Texas Institute for Neurological Disorders". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Texas Institute for Neurological Disorders, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Texas Institute for Neurological Disorders, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".